NCT06442761View on ClinicalTrials.gov

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

PHASE1RecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

July 31, 2028

Conditions

Sickle Cell Disease

Interventions

DRUG

Motixafortide

Given Subcutaneously (under the skin).

Trial Locations (1)

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

BioLineRx, Ltd.

All Listed Sponsors

collaborator

BioLineRx, Ltd.

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER

NCT06442761 - SCD Stem Cell Mobilization and Apheresis Using Motixafortide | Biotech Hunter | Biotech Hunter